OBJECTIVE: Obesity is associated with high insulin and glucagon plasma levels. Enhanced β-cell function and β-cell expansion are responsible for insulin hypersecretion. It is unknown whether hyperglucagonemia is due to α-cell hypersecretion or to an increase in α-cell mass. In this study, we investigated the dynamics of the β-cell and α-cell function and mass in pancreas of obese normoglycemic baboons. METHODS: Pancreatic β- and α-cell volumes were measured in 51 normoglycemic baboons divided into six groups according to overweight severity or duration. Islets morphometric parameters were correlated to overweight and to diverse metabolic and laboratory parameters. RESULTS: Relative α-cell volume (RαV) and relative islet α-cell volume (RIαV) increased significantly with both overweight duration and severity. Conversely, in spite of the induction of insulin resistance, overweight produced only modest effects on relative β-cell volume (RβV) and relative islet β-cell volume (RIβV). Of note, RIβV did not increase neither with overweight duration nor with overweight severity, supposedly because of the concomitant, greater increase in RIαV. Baboons' body weights correlated with serum levels of interleukin-6 and tumor necrosis factor-α soluble receptors, demonstrating that overweight induces abnormal activation of the signaling of two cytokines known to impact differently β- and α-cell viability and replication. CONCLUSION: In conclusion, overweight and insulin resistance induce in baboons a significant increase in α-cell volumes (RαV, RIαV), whereas have minimal effects on the β cells. This study suggests that an increase in the α-cell mass may precede the loss of β cells and the transition to overt hyperglycemia and diabetes.
OBJECTIVE: Obesity is associated with high insulin and glucagon plasma levels. Enhanced β-cell function and β-cell expansion are responsible for insulin hypersecretion. It is unknown whether hyperglucagonemia is due to α-cell hypersecretion or to an increase in α-cell mass. In this study, we investigated the dynamics of the β-cell and α-cell function and mass in pancreas of obese normoglycemic baboons. METHODS: Pancreatic β- and α-cell volumes were measured in 51 normoglycemic baboons divided into six groups according to overweight severity or duration. Islets morphometric parameters were correlated to overweight and to diverse metabolic and laboratory parameters. RESULTS: Relative α-cell volume (RαV) and relative islet α-cell volume (RIαV) increased significantly with both overweight duration and severity. Conversely, in spite of the induction of insulin resistance, overweight produced only modest effects on relative β-cell volume (RβV) and relative islet β-cell volume (RIβV). Of note, RIβV did not increase neither with overweight duration nor with overweight severity, supposedly because of the concomitant, greater increase in RIαV. Baboons' body weights correlated with serum levels of interleukin-6 and tumor necrosis factor-α soluble receptors, demonstrating that overweight induces abnormal activation of the signaling of two cytokines known to impact differently β- and α-cell viability and replication. CONCLUSION: In conclusion, overweight and insulin resistance induce in baboons a significant increase in α-cell volumes (RαV, RIαV), whereas have minimal effects on the β cells. This study suggests that an increase in the α-cell mass may precede the loss of β cells and the transition to overt hyperglycemia and diabetes.
Authors: S B Solerte; M Rondanelli; R Giacchero; M Stabile; E Lovati; L Cravello; B Pontiggia; G Vignati; E Ferrari; M Fioravanti Journal: Int J Obes Relat Metab Disord Date: 1999-09
Authors: K Cusi; K Maezono; A Osman; M Pendergrass; M E Patti; T Pratipanawatr; R A DeFronzo; C R Kahn; L J Mandarino Journal: J Clin Invest Date: 2000-02 Impact factor: 14.808
Authors: Alberto O Chavez; Amalia Gastaldelli; Rodolfo Guardado-Mendoza; Juan C Lopez-Alvarenga; M Michelle Leland; M Elizabeth Tejero; GianPio Sorice; Francesca Casiraghi; Alberto Davalli; Raúl A Bastarrachea; Anthony G Comuzzie; Ralph A DeFronzo; Franco Folli Journal: Cardiovasc Diabetol Date: 2009-04-23 Impact factor: 9.951
Authors: Natalia E Schlabritz-Loutsevitch; Anthony G Comuzzie; Michael M Mahaney; Gene B Hubbard; Edward J Dick; Mehmet Kocak; Sonali Gupta; Maira Carrillo; Mauro Schenone; Arnold Postlethwaite; Andrzej Slominski Journal: Comp Med Date: 2016-04 Impact factor: 0.982
Authors: Rodolfo Guardado Mendoza; Carla Perego; Giovanna Finzi; Stefano La Rosa; Carlo Capella; Lilia M Jimenez-Ceja; Licio A Velloso; Mario J A Saad; Fausto Sessa; Federico Bertuzzi; Stefania Moretti; Edward J Dick; Alberto M Davalli; Franco Folli Journal: Diabetologia Date: 2015-06-07 Impact factor: 10.122
Authors: Teresa Vanessa Fiorentino; Michael Owston; Gregory Abrahamian; Stefano La Rosa; Alessandro Marando; Carla Perego; Eliana S Di Cairano; Giovanna Finzi; Carlo Capella; Fausto Sessa; Francesca Casiraghi; Ana Paez; Ashwin Adivi; Alberto Davalli; Paolo Fiorina; Rodolfo Guardado Mendoza; Anthony G Comuzzie; Mark Sharp; Ralph A DeFronzo; Glenn Halff; Edward J Dick; Franco Folli Journal: Am J Pathol Date: 2014-11-06 Impact factor: 4.307
Authors: Rafael Arrojo e Drigo; Yusuf Ali; Juan Diez; Dinesh Kumar Srinivasan; Per-Olof Berggren; Bernhard O Boehm Journal: Diabetologia Date: 2015-07-28 Impact factor: 10.122
Authors: Francesca Casiraghi; Raweewan Lertwattanarak; Livio Luzi; Alberto O Chavez; Alberto M Davalli; Terry Naegelin; Anthony G Comuzzie; Patricia Frost; Nicolas Musi; Franco Folli Journal: PLoS One Date: 2013-09-19 Impact factor: 3.240